Selected News from Today's FirstWord
Combination of Bristol-Myers Squibb's Yervoy, nivolumab shows promise in early-stage melanoma trial
Bristol-Myers Squibb released preliminary data ahead of the ASCO meeting from an early-stage trial, demonstrating that the combination of Yervoy (ipilimumab) and the investigational PD-1 receptor Full story
- Novartis spokesman denies report of possible bid for Actavis - (Ref. The Wall Street Journal; Yahoo!Health; The Inquirer; FinanzNachrichten)
- Study: Roche's GA101 cuts risk of disease progression, death in patients with CLL - (Ref. Roche; Bloomberg; Chicago Tribune; Romandie)
- AstraZeneca moves three cancer drugs into late-stage development - (Ref. AstraZeneca; Bloomberg; London South East)
Also in the News
- Products:
- carboplatin,
- Geodon,
- hyaluronic acid,
- Lexapro,
- nab-paclitaxel,
- niraparib,
- regorafenib
- Companies:
- Hyperion,
- Oxford BioMedica,
- PARI,
- Pfizer,
- SciClone,
- Senesco,
- ThromboGenics
- Markets:
- Canada,
- India,
- United States,
- World
FirstWord Dossier Reports
www.fwreports.com
**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.Click here to see our recent reports.
Most Read Stories in the Past Week
Recent Reports
- Building Strong Market Access Teams
- Biosimilars Regulatory Update: an evolving landscape
- Pharma Social Media Campaigns: current thinking and future outlook
- Pharma Market Insights: Closed Loop Marketing
- Pharma Sales Force Innovations: technology, training and rewards
- Pharma YouTube Channels: Content and Comment (Nexus Report)
- The Medical Device Outlook in Emerging Markets - (FirstShelf)
- The Hepatitis Market Outlook to 2015 - (FirstShelf)
- Digital Doctors: Marketing to Online Networks
- Generic Substitution: Taking a Narrow View?
- Closing the Loop: Beyond Digital Detailing
- Pharma Marketing in Latin America
- Biosimilars: Surveying the Market Landscape